}

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. The effect of a probiotic on faecal and liver lipid classes in rats.
    The British journal of nutrition (Br J Nutr ) Vol: 73 Issue 5 Pages: 701-10
    Pub: 1995 May Epub:
    • Fukushima M
    • Nakano M

  2. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 61 Issue 1 Pages: 139-42
    Pub: 2008 Jan Epub: 2007 Oct 26
    • López-Brea M
    • Alarcón T
    • Domingo D
    • Díaz-Regañón J

  3. Curated database of commensal, symbiotic and pathogenic microbiota
    Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages:
    Pub: 2014 Jun Epub:
    • D'Adamo Peter

  4. Gut-borne Saccharomyces cerevisiae, a promising candidate for the formulation of feed additives, modulates immune system and gut microbiota.
    Beneficial microbes (Benef Microbes ) Vol: 7 Issue 5 Pages: 659-668
    Pub: 2016 Nov 30 Epub:
    • García G
    • Dogi C
    • de Moreno de LeBlanc A
    • Greco C
    • Cavaglieri L

  5. Effects of probiotic Enterococcus faecium and Saccharomyces cerevisiae on the faecal microflora of pet rabbits.
    The Journal of small animal practice (J Small Anim Pract ) Vol: 55 Issue 9 Pages: 442-6
    Pub: 2014 Sep Epub: 2014 Jun 24
    • Benato L
    • Hastie P
    • O`Shaughnessy P
    • Murray JA
    • Meredith A

  6. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.
    Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 1359
    Pub: 2017 May 2 Epub: 2017 May 2
    • Yu L
    • Zhao XK
    • Cheng ML
    • Yang GZ
    • Wang B
    • Liu HJ
    • Hu YX
    • Zhu LL
    • Zhang S
    • Xiao ZW
    • Liu YM
    • Zhang BF
    • Mu M

  7. Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis.
    Virulence (Virulence ) Vol: 9 Issue 1 Pages: 954-966
    Pub: 2018 Dec 31 Epub:
    • Sabbatini S
    • Monari C
    • Ballet N
    • Mosci P
    • Decherf AC
    • Pélerin F
    • Perito S
    • Scarpelli P
    • Vecchiarelli A

  8. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
    PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0173802
    Pub: 2017 Epub: 2017 Apr 7
    • Villar-García J
    • Güerri-Fernández R
    • Moya A
    • González A
    • Hernández JJ
    • Lerma E
    • Guelar A
    • Sorli L
    • Horcajada JP
    • Artacho A
    • D Auria G
    • Knobel H

  9. Effect of live yeast Saccharomyces cerevisiae (Actisaf Sc 47) supplementation on the performance and hindgut microbiota composition of weanling pigs.
    Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 5315
    Pub: 2018 Mar 28 Epub: 2018 Mar 28
    • Kiros TG
    • Derakhshani H
    • Pinloche E
    • D`Inca R
    • Marshall J
    • Auclair E
    • Khafipour E
    • Van Kessel A

  10. Effects of probiotics Pediococcus acidilactici strain MA18/5M and Saccharomyces cerevisiae subsp. boulardii strain SB-CNCM I-1079 on fecal and intestinal microbiota of nursing and weanling piglets.
    Journal of animal science (J Anim Sci ) Vol: 93 Issue 11 Pages: 5313-26
    Pub: 2015 Nov Epub:
    • Brousseau JP
    • Talbot G
    • Beaudoin F
    • Lauzon K
    • Roy D
    • Lessard M

Full list available by paid subscriptions

For More information see this summary.


This site is a free site for non-commercial use and intended to stay a free site for individuals and practioning individual physicians!

Reverse engineering, data scraping and spidering are strictly provided and will be prosecuted under 18 U.S.C. ┬ž 1030(e)(6) and other statutes. Licensing with an API is available.

If this site is really helpful and you are loaded with money -- Amazon Gift cards are always appreciated to defer operating costs.;-)